专题：Colorectal and Anal Carcinomas

This cluster of papers focuses on the treatment and management of anal cancer, including the use of chemoradiation, intensity-modulated radiation therapy, and chemotherapy. It also explores the impact of HIV infection on treatment outcomes, imaging techniques such as FDG-PET/CT, and the long-term quality of life for survivors. Additionally, it delves into salvage surgery for recurrent or persistent anal cancer.
最新文献
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial

article Full Text OpenAlex

Combining immunotherapy and radiation therapy in gastrointestinal cancers: A review

review Full Text OpenAlex

Uncovering the burden of hidradenitis suppurativa misdiagnosis and underdiagnosis: a machine learning approach

article Full Text OpenAlex

Patient-reported exacerbating factors for hidradenitis suppurativa: A cross sectional study

letter Full Text OpenAlex

Topical imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia lesions (TOPIC‐2): A randomised controlled trial

article Full Text OpenAlex

Clinicopathological factors predict residual lymph node metastasis in locally advanced rectal cancer with ypT0-2 after neoadjuvant chemoradiotherapy

article Full Text OpenAlex

Tumor regression and safe distance of distal margin after neoadjuvant therapy for rectal cancer

article Full Text OpenAlex

A retrospective cohort study of neoadjuvant chemoradiotherapy combined with immune checkpoint inhibitors in locally advanced rectal cancer

article Full Text OpenAlex

Increased cancer incidence among patients with hidradenitis suppurativa – a Danish nationwide register study 1977–2017

article Full Text OpenAlex

Unraveling variations and enhancing prediction of successful sphincter-preserving resection for low rectal cancer: a post hoc analysis of the multicentre LASRE randomized clinical trial

article Full Text OpenAlex

近5年高被引文献
Current treatment and recent progress in gastric cancer

review Full Text OpenAlex 1647 FWCI243.73132667

PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer

article Full Text OpenAlex 1363 FWCI282.30715518

Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

article Full Text OpenAlex 1122 FWCI230.30590531

Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial

article Full Text OpenAlex 1089 FWCI84.70384682

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

article Full Text OpenAlex 876 FWCI70.2371007

Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy

article Full Text OpenAlex 759 FWCI112.46834483

Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

article Full Text OpenAlex 720 FWCI102.48771026

The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021

article Full Text OpenAlex 628 FWCI93.21219823

NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022

article Full Text OpenAlex 481 FWCI133.61265109

Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study

article Full Text OpenAlex 481 FWCI41.09394549